TY - JOUR
T1 - Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology
AU - Tinazzi, Michele
AU - Geroin, Christian
AU - Erro, Roberto
AU - Marcuzzo, Enrico
AU - Cuoco, Sofia
AU - Ceravolo, Roberto
AU - Mazzucchi, Sonia
AU - Pilotto, Andrea
AU - Padovani, Alessandro
AU - Romito, Luigi Michele
AU - Eleopra, Roberto
AU - Zappia, Mario
AU - Nicoletti, Alessandra
AU - Dallocchio, Carlo
AU - Arbasino, Carla
AU - Bono, Francesco
AU - Pascarella, Angelo
AU - Demartini, Benedetta
AU - Gambini, Orsola
AU - Modugno, Nicola
AU - Olivola, Enrica
AU - Bonanni, Laura
AU - Antelmi, Elena
AU - Zanolin, Elisabetta
AU - Albanese, Alberto
AU - Ferrazzano, Gina
AU - De Micco, Rosa
AU - Lopiano, Leonardo
AU - Calandra-Buonaura, Giovanna
AU - Petracca, Martina
AU - Esposito, Marcello
AU - Pisani, Antonio
AU - Manganotti, Paolo
AU - Stocchi, Fabrizio
AU - Coletti Moja, Mario
AU - Antonini, Angelo
AU - Ercoli, Tommaso
AU - Morgante, Francesca
PY - 2021
Y1 - 2021
N2 - Background and purpose: The aims of this study were to describe the clinical manifestations of functional motor disorders (FMDs) coexisting with other neurological diseases (“comorbid FMDs”), and to compare comorbid FMDs with FMDs not overlapping with other neurological diseases (“pure FMDs”). Methods: For this multicenter observational study, we enrolled outpatients with a definite FMD diagnosis attending 25 tertiary movement disorder centers in Italy. Each patient with FMDs underwent a detailed clinical assessment including screening for other associated neurological conditions. Group comparisons (comorbid FMDs vs. pure FMDs) were performed in order to compare demographic and clinical variables. Logistic regression models were created to estimate the adjusted odds ratios (95% confidence intervals) of comorbid FMDs (dependent variable) in relation to sociodemographic and clinical characteristics (independent variables). Results: Out of 410 FMDs, 21.7% of patients (n = 89) had comorbid FMDs. The most frequent coexisting neurological diseases were migraine, cerebrovascular disease and parkinsonism. In the majority of cases (86.5%), FMDs appeared after the diagnosis of a neurological disease. Patients with comorbid FMDs were older, and more frequently had tremor, non-neurological comorbidities, paroxysmal non-epileptic seizures, major depressive disorders, and benzodiazepine intake. Multivariate regression analysis showed that diagnosis of comorbid FMDs was more likely associated with longer time lag until the final diagnosis of FMD, presence of tremor and non-neurological comorbidities. Conclusions: Our findings highlight the need for prompt diagnosis of FMDs, given the relatively high frequency of associated neurological and non-neurological diseases.
AB - Background and purpose: The aims of this study were to describe the clinical manifestations of functional motor disorders (FMDs) coexisting with other neurological diseases (“comorbid FMDs”), and to compare comorbid FMDs with FMDs not overlapping with other neurological diseases (“pure FMDs”). Methods: For this multicenter observational study, we enrolled outpatients with a definite FMD diagnosis attending 25 tertiary movement disorder centers in Italy. Each patient with FMDs underwent a detailed clinical assessment including screening for other associated neurological conditions. Group comparisons (comorbid FMDs vs. pure FMDs) were performed in order to compare demographic and clinical variables. Logistic regression models were created to estimate the adjusted odds ratios (95% confidence intervals) of comorbid FMDs (dependent variable) in relation to sociodemographic and clinical characteristics (independent variables). Results: Out of 410 FMDs, 21.7% of patients (n = 89) had comorbid FMDs. The most frequent coexisting neurological diseases were migraine, cerebrovascular disease and parkinsonism. In the majority of cases (86.5%), FMDs appeared after the diagnosis of a neurological disease. Patients with comorbid FMDs were older, and more frequently had tremor, non-neurological comorbidities, paroxysmal non-epileptic seizures, major depressive disorders, and benzodiazepine intake. Multivariate regression analysis showed that diagnosis of comorbid FMDs was more likely associated with longer time lag until the final diagnosis of FMD, presence of tremor and non-neurological comorbidities. Conclusions: Our findings highlight the need for prompt diagnosis of FMDs, given the relatively high frequency of associated neurological and non-neurological diseases.
KW - dystonia
KW - functional neurological disorders
KW - neurological diseases
KW - tremor
KW - dystonia
KW - functional neurological disorders
KW - neurological diseases
KW - tremor
UR - http://hdl.handle.net/10807/166989
U2 - 10.1111/ene.14674
DO - 10.1111/ene.14674
M3 - Article
SN - 1351-5101
VL - 28
SP - 1752
EP - 1758
JO - European Journal of Neurology
JF - European Journal of Neurology
ER -